STOCK TITAN

Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes

(Neutral)
Tags

Haleon (LSE/NYSE: HLN) announced the pricing terms, expiration and preliminary results of its cash tender offer for any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 issued by Haleon US Capital.

As of the 5:00 p.m. New York time expiration on 18 August 2026, holders had tendered $1,342,272,000 principal amount. According to Haleon, accepted notes are expected to receive total consideration of $996.23 per $1,000 principal, based on a 3.921% reference yield and 10 bps fixed spread, plus accrued interest to but excluding the settlement date. The offer is conditioned on completion of a new USD-denominated senior fixed rate notes issuance, with both the new issue and tender offer settlement expected on 21 August 2026. Accepted notes will cease accruing interest on the settlement date and will be cancelled. The notes are fully and unconditionally guaranteed by Haleon.

Loading...
Loading translation...

Positive

  • $1,342,272,000 principal tendered, enabling sizeable reduction of 2027 notes
  • Repurchase price of $996.23 per $1,000 below par value
  • Interest on Accepted Notes ceases on 21 August 2026, reducing future coupon outflows

Negative

  • Cash outlay to repurchase up to $1,342,272,000 of notes
  • Tender Offer completion dependent on successful new USD notes issuance by 21 August 2026

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LONDON, Aug. 19, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces the pricing terms, expiration and results of the offer to buy back any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 (the "Notes") of Haleon US Capital LLC's (the "Offeror"), the Company's wholly owned subsidiary (the "Tender Offer").

The Tender Offer has been made upon the terms and subject to the conditions set forth in the Offer to Purchase dated 11 August 2026 (the "Offer to Purchase"). Terms not defined in this announcement have the meanings given to them in the Offer to Purchase.

Upon the terms and subject to the conditions set forth in the Offer to Purchase, the Offeror expects to purchase any and all of the Notes validly tendered and not withdrawn, as set forth in the table below under "Principal Amount Tendered" (the "Accepted Notes").

Title of Notes(1)

ISIN/CUSIP

Reference
Security
(2)

Fixed
Spread
(2)

Bloomberg
Reference
Page

Reference
Yield

Total
Consideration
(per $1,000
Principal
Amount)
(2)

Principal
Amount
Tendered
(3)

$1,999,350,000

3.375% Fixed Rate
Senior Notes due
2027

ISIN:

Registered:
US36264FAK75

144A:
US36264FAB76

Reg S:
USU04020AB65

CUSIP:
Registered: 36264F
AK7

144A: 36264F AB7

Reg S: U04020 AB6

3.875% UST
due March
31, 2027

10 bps

FIT3

3.921 %

$996.23

$1,342,272,000

(1)

The Notes are fully and unconditionally guaranteed by Haleon.

(2)

The "Total Consideration" per $1,000 principal amount of Accepted Notes has been calculated as described in the Offer to Purchase using the Fixed Spread. See "Description of the Tender Offer—Total Consideration" in the Offer to Purchase. The Total Consideration does not include accrued and unpaid interest on such Accepted Notes from the last interest payment date to, but not including, the Settlement Date (the "Accrued Interest"), which will be paid in addition to the Total Consideration.

(3)

As provided to the Company by the Tender and Information Agent.

The Tender Offer expired at 5:00 p.m., New York City time, on 18 August 2026 (such date and time, the "Expiration Date").

The consummation of the Tender Offer is subject to, and conditioned upon, the satisfaction or waiver, where permitted, of the conditions discussed in the Offer to Purchase, including that the Offeror successfully complete (on terms satisfactory to it in its sole discretion) and settles the proposed offering of USD-denominated Senior Fixed Rate Notes announced on 11 August 2026 (the "New Notes Condition"). The Offeror expects that the New Notes Condition will be satisfied on 21 August 2026 and that the Settlement Date for the Tender Offer will be 21 August 2026.

Upon the terms and subject to the conditions set forth in the Offer to Purchase, Holders of Accepted Notes will receive the "Total Consideration". In addition, Holders of Accepted Notes will be paid the Accrued Interest on the Settlement Date. Interest will cease to accrue on the Settlement Date for all Accepted Notes. Accepted Notes purchased in the Tender Offer will be cancelled.

This press release will be available on www.haleon.com. Copies of the Offer to Purchase are available to holders of the Notes ("Holders") through the Tender and Information Agent, Global Bondholder Services Corporation at its website https://www.gbsc-usa.com/haleon/ or by calling (212) 430-3774 (bank and brokers call collect) or (855) 654-2014 (all others please call toll-free).

The Dealer Managers for the Tender Offer are:

Merrill Lynch International

2 King Edward Street

London EC1A 1HQ

United Kingdom

Attention: Liability Management Group

Telephone (Europe): +44 20 7996 5420

Telephone (U.S. Toll Free): +1 (888) 292-0070

Telephone (U.S.): +1 (980) 387-3907

Email: DG.LM-EMEA@bofa.com

RBC Capital Markets, LLC

Brookfield Place

200 Vesey Street, 8th Floor

New York, NY 10281

Attention: Liability Management Group

In Europe: +44 20 7029 0113

Toll-Free: (877) 381-2099

Collect: (212) 618-7843

Email: liability.management@rbccm.com

The Tender and Information Agent for the Tender Offer is:

Global Bondholder Services Corporation

65 Broadway – Suite 404
New York, New York 10006
Attn: Corporate Actions

Banks and Brokers Call Collect: (212) 430-3774
All Others Please Call Toll-Free: (855) 654-2014
E-mail: contact@gbsc-usa.com
Tender Offer Website: https://www.gbsc-usa.com/haleon/

The Offeror has not filed this announcement or the Offer to Purchase with, and they have not been reviewed by, any federal or state securities commission or regulatory authority of any other country. No authority has passed upon the accuracy or adequacy of the Tender Offer, and it is unlawful and may be a criminal offense to make any representation to the contrary.

This announcement is for informational purposes only and is not an offer to buy, or the solicitation of an offer to sell, any of the Notes and the Offer to Purchase does not constitute an offer to purchase Notes in any jurisdiction in which, or to or from any person to or from whom, it is unlawful to make such offer under applicable securities or blue sky laws.

Cautionary note regarding forward-looking statements

Certain statements contained in this announcement are, or may be deemed to be, "forward-looking statements". Forward-looking statements give Haleon's current expectations and projections about future events, including strategic initiatives and future financial condition and performance, and so Haleon's actual results may differ materially from what is expressed or implied by such forward-looking statements. Forward-looking statements sometimes use words such as "expects," "anticipates," "believes," "targets," "plans," "intends," "aims," "projects," "indicates," "may," "might," "will," "should," "potential," "could" and words of similar meaning (or the negative thereof). All statements, other than statements of historical facts, included in this announcement are forward-looking statements. Such forward-looking statements include, but are not limited to, statements relating to the New Notes Condition and expected settlement of the Tender Offer, future actions, prospective products or product approvals, delivery on strategic initiatives (including but not limited to acquisitions, realizations of efficiencies and responsible business goals), future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, dividend payments and financial results.

Any forward-looking statements made by or on behalf of Haleon speak only as of the date they are made and are based upon the knowledge and information available to Haleon on the date of this announcement. These statements and views may be based on a number of assumptions and, by their nature, involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future and/or are beyond Haleon's control or precise estimate. Subject to our obligations under English and U.S. law in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Enquiries

Investors

Media

Jo Russell

+44 7787 392441

Zoë Bird

+44 7736 746167

Rakesh Patel

+44 7552 484646

Gemma Thomas

+44 7985 175048

Email: investor-relations@haleon.com

Email: corporate.media@haleon.com



Treasury


Mike Rowe

+44 7775 012365


Ben Checkland

+44 7823 370368


Email: cf-treasury@haleon.com


About Haleon 
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com

Cision View original content:https://www.prnewswire.com/news-releases/haleon-plc-announces-pricing-terms-expiration-and-results-of-its-cash-tender-offer-for-outstanding-2027-notes-302854738.html

SOURCE Haleon plc

FAQ

What did Haleon (HLN) announce about its 2027 notes tender offer on 19 August 2026?

Haleon announced pricing terms, expiration and results for its cash tender offer for its 3.375% Senior Notes due 2027. According to Haleon, the offer targeted any and all of the $1,999,350,000 outstanding notes issued by Haleon US Capital and guaranteed by Haleon.

How much of Haleon’s 3.375% 2027 notes (HLN) were tendered in the cash offer?

Haleon reported that $1,342,272,000 principal amount of the 3.375% Senior Notes due 2027 was validly tendered. According to Haleon, these are the “Accepted Notes” expected to be purchased, subject to the conditions outlined in the Offer to Purchase, including the New Notes Condition.

What total consideration will holders of Haleon (HLN) 2027 notes receive in the tender offer?

Holders of Accepted Notes are expected to receive total consideration of $996.23 per $1,000 principal amount. According to Haleon, this amount is based on a 3.921% reference yield plus a 10 bps fixed spread, excluding separate accrued and unpaid interest to the settlement date.

When did Haleon’s cash tender offer for its 2027 notes (HLN) expire and when will it settle?

The tender offer expired at 5:00 p.m. New York City time on 18 August 2026. According to Haleon, the settlement date is expected to be 21 August 2026, subject to satisfaction of the New Notes Condition related to a new USD-denominated notes offering.

What is the New Notes Condition in Haleon’s (HLN) 2027 notes tender offer?

The New Notes Condition requires successful completion and settlement of a proposed offering of USD-denominated Senior Fixed Rate Notes. According to Haleon, the Offeror expects this condition to be satisfied on 21 August 2026, allowing the tender offer to settle on the same date.

Will Haleon (HLN) pay accrued interest on the 2027 notes accepted in the tender offer?

Yes, holders of Accepted Notes will receive accrued and unpaid interest in addition to the total consideration. According to Haleon, interest accrues from the last interest payment date to, but not including, the settlement date, after which interest on Accepted Notes will cease.

What happens to Haleon’s 3.375% 2027 notes (HLN) purchased in the tender offer?

Accepted Notes purchased in the tender offer will be cancelled. According to Haleon, interest on these notes will cease to accrue on the settlement date, permanently removing the repurchased principal from Haleon’s outstanding 3.375% Senior Notes due March 2027.